Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.
OBJECTIVE
To study effects of inhibition of glycation, and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.


METHODS
Diabetes was induced in male Wistar rats with streptozocin (STZ; 60 mg/kg BW, i.p.). Diabetic as well as strain matched control rats were fed 1) a normal diet, 2) addition of aminoguanidine in the drinking water (0.5 g/l for diabetic rats and 1.0 g/l for control rats) or 3) probucol in the pellets (1% w/w). After 6 months, the number of acellular vessels, endothelial cells and pericytes were counted in trypsin digested retinal vessel preparations, and the total retinal tissue amount of glutathione (GSH) and cysteine was measured with HPLC.


RESULTS
Cataract formation occurred after 13 weeks in diabetic animals compared with 17 weeks for those treated with aminoguanidine, and 16 weeks for those treated with probucol (p < 0.001 in both cases). Aminoguanidine inhibited the formation of acellular collapsed capillary strands, 9 (3-14) vs. 18 (12-262) (median, range) per quadrant in untreated diabetic rats (p = 0.004), while probucol did not have any effect. Neither aminoguanidine, nor probucol influenced the endothelial/pericyte ratio. Diabetes caused a reduction in the GSH/cysteine ratio (10.7 +/- 0.6 vs. 15.3 +/- 1. 5) (mean +/- SD; p < 0.001). Probucol partly restored this imbalance (p < 0.05) whereas aminoguanidine did not.


CONCLUSIONS
The results indicate that cataract formation in diabetes involves both glycation and oxidative stress processes. The reduced formation of acellular collapsed capillary strands by aminoguanidine suggests a potential role for glycation in vascular damage. The positive effect of probucol on cysteine/GSH metabolism imbalance indicates that derangements of one of the retinal defense systems against oxidative stress can be normalized by antioxidants.
Agardh
E
E
Department of Ophthalmology, University Hospital MAS, Malmö, Sweden. agardh@endo.mas.lu.se
Hultberg
B
B
Agardh
C
C
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight; D002386:Cataract / Q000139:chemically induced / Q000209:etiology*; D003545:Cysteine / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000150:complications* / Q000473:pathology; D003930:Diabetic Retinopathy / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D005978:Glutathione / Q000378:metabolism; D006031:Glycosylation; D006146:Guanidines / Q000494:pharmacology; D008297:Male; D018384:Oxidative Stress / Q000502:physiology*; D011341:Probucol / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012160:Retina / Q000378:metabolism; D012171:Retinal Vessels / Q000187:drug effects / Q000473:pathology
D001786:Blood Glucose; D006146:Guanidines; D005978:Glutathione; D003545:Cysteine; D011341:Probucol; C004479:pimagedine